Smartphone Apps Launched for Atrial Fibrillation Patients and their Healthcare Providers

Novel smartphone and tablet applications (apps) for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace,(1) with a summary published in the European Heart Journal.(2)

Atrial fibrillation is the most common heart rhythm disorder and significantly increases the risk of stroke and death. One in four middle-aged adults in Europe and the US will develop atrial fibrillation, and the incidence and prevalence are rising.

"Around two-thirds of people in Europe and the US have a mobile device and use it as their main way of accessing online information," said lead author Dr Dipak Kotecha, a clinician scientist in cardiovascular medicine at the Institute of Cardiovascular Sciences, University of Birmingham, UK. "This presents a big opportunity to improve self management and shared decision making in atrial fibrillation."

The My AF app and AF Manager app were designed by the European Society of Cardiology (ESC) Guidelines Task Force on Atrial Fibrillation and the CATCH ME consortium of which the ESC is a partner. The apps were developed over the last two years in tandem with the writing of the 2016 ESC Guidelines on atrial fibrillation.(3)

Both apps are freely available for Android and iOS devices through the Google Play, and Apple stores.

My AF is for patients with atrial fibrillation. It provides information about the condition, the risk of stroke, atrial fibrillation treatments, and tips on improving lifestyle. Patients can record symptoms and quality of life in a diary which can be shared with a nominated health professional before each consultation to maximise face-to-face time.

Developed in collaboration with patients and patient support groups, My AF provides high quality information in a simple format which is suitable for adults of all ages. Work is underway to translate the app into several languages.

Dr Kotecha said: "The app aims to encourage active patient involvement in the management of their condition. There is evidence that patient education can improve self-care, adherence to therapy, and long-term outcomes."

AF Manager is for doctors, nurses and other healthcare professionals. It is the first app of its kind to be submitted for CE certification and is in the final stages of approval. AF Manager imports information shared by the patient and allows the healthcare professional to amend details and enter other medical information, such as electrocardiogram or echocardiography data. The Treatment Manager tool within the app then suggests individualised treatment options based on ESC guidelines.(4) After a consultation, the notes, treatment decisions, and medication dosages can be entered and then shared with the patient.

"Many studies have shown that when clinicians follow guideline recommendations, patients have better outcomes," said Dr Kotecha. "All of the decision aids in AF Manager are based on ESC guidelines so we hope this will encourage guideline implementation. Patients will have the option to anonymously donate their data which will enable us to assess the guideline adherence rate."

The apps are linked to allow transfer of data between patients and healthcare professionals via a secure server at the University of Birmingham, UK. Patients control who can view and edit their data. When data sharing is enabled, updates are synced on both apps. All shared information is encrypted and password protected.

Dr Kotecha said: "We know that effective management of atrial fibrillation is suited to shared decision making and we have created the apps in the hope of facilitating this process. Sharing information should save clinicians time and enable them to devote consultations to choosing the best treatments."

He concluded: "The dynamic nature of this technology will allow us to modify and update the features and content to reflect feedback from users, as well as future versions of the ESC atrial fibrillation guidelines."

About the CATCH ME consortium
The CATCH ME (Characterising Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly) Consortium is a European collaboration which aims to improve the prevention and treatment of atrial fibrillation and its complications. CATCH ME is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633196.

About the European Society of Cardiology
The ESC brings together health care professionals from more than 140 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.

1. Kotecha D, et al. European Society of Cardiology (ESC) smartphone and tablet applications for patients with atrial fibrillation and their healthcare providers. EP Europace. 2017. DOI: 10.1093/europace/eux299
2. Kotecha D, Kirchhof P. ESC Apps for Atrial Fibrillation. Eur Heart J. 2017;38:2643–2645.
3. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. doi: 10.1093/eurheartj/ehw210
4. The full capabilities of the Treatment Manager tool will be available once the app is CE certified.

Most Popular Now

Study Finds AI Accurately Detects Fractu…

Emergency room and urgent care clinics are typically busy and patients often have to wait many hours before they can be seen, evaluated and receive treatment. Waiting for x-rays to...

Oracle Buys Cerner

Oracle Corporation (NYSE: ORCL) and Cerner Corporation jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in...

Philips and IJsselland Hospital Sign Lon…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle aan den Ijssel, The Netherlands)...

Start of the European FAST III Study: An…

The first patients were recently enrolled in the FAST III trial at the Erasmus University Medical Center in Rotterdam, The Netherlands. This officially marked the beginning of a multicenter, randomized-controlled...

Computer Programs and Mobile Apps may He…

The COVID-19 pandemic has had a major impact on mental health across the globe. Depression is predicted to be the leading cause of lost life years due to illness by...

AI Points the Way to Better Doctor-Patie…

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand...

Could EKGs Help Doctors use AI to Detect…

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI)...

Mayo Clinic Researchers Use AI, Biomarke…

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients...

Open Call DIGITAL-2021-DEPLOY-01-TWINS-H…

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an...

4.5 Million Euros in EU Funding for Saar…

This year, three computer scientists from Saarbrücken were awarded an "ERC Starting Grant" by the European Research Council. This award, endowed with 1.5 million euros each, is among the most...

Mjog by Livi Launches Remote Monitoring …

Mjog by Livi has launched a remote monitoring tool that will help GPs support and monitor people with depression through messages sent to their smartphones. The latest data from the Office...